Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vatner

Showing results (51-60 of 550) with videos related to

Pageof 55
Sort By:
Hypertension (Dallas, Tex. : 1979)|May 1, 1985
beta-Adrenergic and cholinergic receptors in hypertension-induced hypertrophyD E Vatner, D A Kirby, C J Homcy, et al.
Heart Failure Reviews|July 27, 2010
Modulation of beta-adrenergic receptor signaling in heart failure and longevity: targeting adenylyl cyclase type 5David Ho, Lin Yan, Kousaku Iwatsubo, et al.
Journal of Molecular and Cellular Cardiology|February 22, 2001
Beta-adrenergic cardiac hypertrophy is mediated primarily by the beta(1)-subtype in the rat heartC Morisco, D C Zebrowski, D E Vatner, et al.
The American Journal of Physiology|April 1, 1993
Increased alpha 1-adrenergic vascular sensitivity during development of hypertension in conscious dogsN Uemura, D E Vatner, Y T Shen, et al.
The American Journal of Physiology|November 1, 1995
Adrenergic responsiveness is reduced, while baseline cardiac function is preserved in old adult conscious monkeysN Sato, K Kiuchi, Y T Shen, et al.
Circulation|September 1, 1994
Decrease in myocardial ryanodine receptors and altered excitation-contraction coupling early in the development of heart failureD E Vatner, N Sato, K Kiuchi, et al.
Science (New York, N.Y.)|June 10, 2017
Minority investigators lack NIH fundingJohn J Guers, Judith Gwathmey, Georges Haddad, et al.
The Journal of Pharmacology and Experimental Therapeutics|March 5, 2016
A Food and Drug Administration-Approved Antiviral Agent that Inhibits Adenylyl Cyclase Type 5 Protects the Ischemic Heart Even When Administered after ReperfusionClaudio A Bravo, Dorothy E Vatner, Ronald Pachon, et al.
Aging Cell|March 11, 2023
Exercise enhancement by RGS14 disruption is mediated by brown adipose tissueDorothy E Vatner, Marko Oydanich, Jie Zhang, et al.
Ageing Research Reviews|February 2, 2026
Blood Flow and Angiogenesis; Major Mechanisms Mediating Healthful LongevityJie Zhang, Dorothy E Vatner, Ahmed Gad, et al.
Pageof 55

Showing results (51-60 of 550) with videos related to

Sort By:
Pageof 55
Hypertension (Dallas, Tex. : 1979)|May 1, 1985
beta-Adrenergic and cholinergic receptors in hypertension-induced hypertrophyD E Vatner, D A Kirby, C J Homcy, et al.
Heart Failure Reviews|July 27, 2010
Modulation of beta-adrenergic receptor signaling in heart failure and longevity: targeting adenylyl cyclase type 5David Ho, Lin Yan, Kousaku Iwatsubo, et al.
Journal of Molecular and Cellular Cardiology|February 22, 2001
Beta-adrenergic cardiac hypertrophy is mediated primarily by the beta(1)-subtype in the rat heartC Morisco, D C Zebrowski, D E Vatner, et al.
The American Journal of Physiology|April 1, 1993
Increased alpha 1-adrenergic vascular sensitivity during development of hypertension in conscious dogsN Uemura, D E Vatner, Y T Shen, et al.
The American Journal of Physiology|November 1, 1995
Adrenergic responsiveness is reduced, while baseline cardiac function is preserved in old adult conscious monkeysN Sato, K Kiuchi, Y T Shen, et al.
Circulation|September 1, 1994
Decrease in myocardial ryanodine receptors and altered excitation-contraction coupling early in the development of heart failureD E Vatner, N Sato, K Kiuchi, et al.
Science (New York, N.Y.)|June 10, 2017
Minority investigators lack NIH fundingJohn J Guers, Judith Gwathmey, Georges Haddad, et al.
The Journal of Pharmacology and Experimental Therapeutics|March 5, 2016
A Food and Drug Administration-Approved Antiviral Agent that Inhibits Adenylyl Cyclase Type 5 Protects the Ischemic Heart Even When Administered after ReperfusionClaudio A Bravo, Dorothy E Vatner, Ronald Pachon, et al.
Aging Cell|March 11, 2023
Exercise enhancement by RGS14 disruption is mediated by brown adipose tissueDorothy E Vatner, Marko Oydanich, Jie Zhang, et al.
Ageing Research Reviews|February 2, 2026
Blood Flow and Angiogenesis; Major Mechanisms Mediating Healthful LongevityJie Zhang, Dorothy E Vatner, Ahmed Gad, et al.
Pageof 55